The Effects of Laparoscopic Surgery and Nosocomial Infections on the Cost of Care: Evidence from Three Common Surgical Procedures  by Gunnarsson, Candace et al.
The Effects of Laparoscopic Surgery and Nosocomial
Infections on the Cost of Care: Evidence fromThree Common
Surgical Procedures
Candace Gunnarsson, EdD,1 John A. Rizzo, PhD,2 Louis Hochheiser, MD3
1Statistical Solutions, Cincinnati, OH, USA; 2Departments of Preventive Medicine & Economics, Stony Brook University, Stony Brook, NY,
USA; 3Professor Emeritus Family Practice, University of Vermont College of Medicine, Burlington,VT, USA
ABSTRACT
Objective: To examine the cost of care for laparoscopic versus open
surgery and the added cost of nosocomial infections for three common
surgical procedures: cholecystectomy, hysterectomy, and appendectomy.
Methods: The Cardinal Health database repository was utilized to extract
reimbursement data for laparoscopic and open cholecystectomy, hysterec-
tomy, and appendectomy surgical procedures. Utilizing a 22-hospital
sample and a Health Insurance Portability and Accountability Act compli-
ant clinical data extraction technique, the Cardinal Health database reposi-
tory produced a Nosocomial Infection Marker to identify and track
nosocomial infection rates for these procedures. ICD-9 codes were utilized
to identify 10,731 patients who had undergone these procedures between
September 2004 and December 2006. Multivariable linear regression
models were estimated to isolate the effects of laparoscopic versus open
surgery and nosocomial infections on the cost of care.
Results: Laparoscopic surgery signiﬁcantly reduces the overall cost of care
for cholecystectomies, hysterectomies, and appendectomies. Controlling
for the cost of nosocomial infection, incremental cost savings from lap-
aroscopic versus open surgery for all three procedures average $1608.
Cholecystectomy has the largest savings ($3299), followed by hysterec-
tomy ($1385) and appendectomy ($1032). These cost savings in part
reﬂect that patients undergoing laparoscopic procedures have shorter
lengths of stay. In contrast, nosocomial infection increases costs substan-
tially for each surgery type, raising costs for cholecystectomy by $4794,
hysterectomy by $4528, and appendectomy by $6108.
Conclusion: The cost of care for laparoscopic surgery is lower than open
surgery for cholecystectomy, hysterectomy, and appendectomy. This con-
clusion is based on actual hospital reimbursement data.
Keywords: laparoscopic appendectomy, laparoscopic cholecystectomy,
laparoscopic hysterectomy, nosocomial infection, Nosocomial Infection
Marker.
Introduction
For a variety of surgeries, the laparoscopic approach has been
shown to involve less pain, shorter hospitalizations, improved
cosmesis, and faster recovery times than open procedures [1–5].
In contrast, nosocomial infections have been associated with
longer hospitalizations and slower recovery times [6–8].
However, the impact of both laparoscopic surgery and nosoco-
mial infection on the cost of care has not been well delineated.
This study seeks to quantify these relationships for three
common surgical procedures: cholecystectomy, hysterectomy,
and appendectomy.
The foundation of the study is a unique database constructed
by a subsidiary of Cardinal Health (a major provider of health-
care industry services and products) that captures current
reimbursement and provider experience with these surgical treat-
ments while identifying associated nosocomial infections. This
tool enables a more accurate cost assessment compared with
previously published works that relied on charges, which often
differ substantially from reimbursement, and data that are sig-
niﬁcantly older.
In evaluating the cost advantages of laparoscopic versus open
surgery, it is acknowledged that the adoption rates of various
laparoscopic procedures are quite variable. For example, by
1994 more than 85% of cholecystectomies were performed lap-
aroscopically [9], a ﬁgure that may now be as high as 90% [10],
making laparoscopic surgery the standard of care for that pro-
cedure [11,12]. For hysterectomies and appendectomies,
however, the adoption rates have been much slower [13,14]. In
the case of hysterectomy, the relatively slow adoption of laparo-
scopic technique is somewhat surprising given that prospective
randomized clinical trials have demonstrated that total laparo-
scopic hysterectomy and laparoscopically assisted vaginal hyster-
ectomies for benign diseases involve less postoperative pain and
blood loss, fewer transfusions, and faster recovery times, with
complication rates similar to that of abdominal hysterectomy
[15]. In contrast to the proﬁle of laparoscopic hysterectomy, the
clinical advantages of laparoscopic versus open appendectomy
remain controversial. There is currently no consensus as to
whether laparoscopy or open surgery should be the routine choice
for acute appendicitis.
In addition to the clinical advantages of reduced pain and
faster recovery times, there is now evidence that infection rates
following laparoscopic surgery are lower than those for open
surgery. In a recent study utilizing the Cardinal Health data-
base, laparoscopic cholecystectomy and hysterectomy were
shown to each reduce the overall odds of acquiring nosocomial
infections by more than 50% (P < 0.01). Laparoscopic chole-
cystectomy and hysterectomy also resulted in statistically
signiﬁcantly fewer readmissions with nosocomial infections
(P < 0.01) [16].
In surgical patients overall, rates of nosocomial infection have
been reported to range from 1.9% to 25.4%, depending upon the
procedure [17], and often add signiﬁcantly to the costs of health
care. To date, however, there is relatively little information quan-
tifying the effects of nosocomial infections on the cost of care for
speciﬁc surgical procedures.
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Costs of Care for Laparoscopic Surgery
A review of the literature suggests that the economic impact of
laparoscopic surgery in comparison with open procedures
remains inconclusive. In the case of cholecystectomy, for
example, some studies report that laparoscopic surgery increased
costs for hospitalization [18–21], while others have reached the
opposite conclusion [22–31]. Still other studies have found no
signiﬁcant differences in costs associated with laparoscopic
versus open surgery [32,33]. One study determined that laparo-
scopic cholecystectomy initially cost more than open procedures,
but that costs declined once physicians gained sufﬁcient experi-
ence with the procedure [34].
Most studies comparing the costs of laparoscopic with open
hysterectomy have concluded that laparoscopic surgery is more
costly [35–43], although several report little or no difference in
cost [44–47]. Results appear most divergent for appendectomy.
While many studies conclude that laparoscopic appendectomy is
more costly [47–57], others report little or no difference [58–65],
or a cost advantage for laparoscopic appendectomy [66–70].
In addition to obtaining inconclusive results, the cost litera-
ture on laparoscopic cholecystectomy, hysterectomy, and appen-
dectomy has largely employed charge data, which may differ
substantially from the actual amount reimbursed to the hospital.
For example, the charges that a hospital submits for payment
generally exceed the amount actually paid to the hospital, some-
times substantially so. This renders results using charge data less
relevant from both payer and provider perspectives. Moreover,
previous studies typically employed smaller sample sizes than the
present analysis and may have lacked sufﬁcient power to detect
some differences. Finally, earlier work in this area examined data
that are at least 10 years old. Such data reﬂect neither current
reimbursement practices nor the level of familiarity with laparo-
scopic procedures among contemporary physicians.
Costs of Care for Nosocomial Infection
A number of studies have attempted to quantify the costs of
nosocomial infections [6–8,71–81]. While estimates vary, noso-
comial infections have been found to raise hospitalization costs
substantially, often ranging from several thousand dollars to
more than 10 thousand. Typically, previous cost estimates of
nosocomial infection have focused on the intensive care unit, or
have assessed nosocomial infection costs throughout the hospi-
tal. Studies that have examined nosocomial infection costs for
speciﬁc surgeries generally explore the costs of surgical site infec-
tions only. Our analysis explores the cost implications of the
broader measure of nosocomial infection as it includes infections
coming from more than just the surgical site in patients under-
going cholecystectomy, hysterectomy, or appendectomy.
Methods
Data
We utilized a unique database that includes reimbursement infor-
mation that is updated daily. Hence, it captures the latest reim-
bursement practices and provider experience with laparoscopic
and open procedures.
Data were obtained and analyzed by a Cardinal Health sub-
sidiary, which identiﬁes, monitors and tracks nosocomial infec-
tion rates for hospitals. The subsidiary company houses data
from 10.3 million admissions from US hospitals in 28 states and
2.7 million admissions including corresponding ﬁnancial data.
Using ICD-9 procedure codes supplied by hospitals, patients
having undergone open and laparoscopic cholecystectomy, hys-
terectomy, or appendectomy procedures were identiﬁed to deter-
mine the effects of laparoscopic versus open procedures on the
costs of care for these three surgeries. In this database, the costs
of care are measured as the actual payments received from payers
for each procedure and thus are costs from the payer perspective.
Financial data are obtained annually from client hospitals as
a part of the Nosocomial Infection Marker (NIM) Surveillance
Service. The clinical and ﬁnancial data are aggregated into a
single database allowing for analysis of clinical and ﬁnancial
outcomes studies. The data utilized in this analysis were collected
between September 1, 2004 and December 31, 2006 from 22
hospitals in 15 states. The hospitals were primarily tertiary non-
major trauma hospitals. These hospitals had a median number of
359 beds, with an interquartile range from 191 to 483 beds; one
hospital exceeded 1000 beds and two had fewer than 150.
Only those subjects undergoing cholecystectomy, hysterec-
tomy, or appendectomy were extracted from the database.
Primary ICD-9 procedure codes were used to identify both pro-
cedure and type of surgery (laparoscopic vs. open). Including
only patients with a primary ICD-9 procedure code for one of the
three surgical modalities ensures that the surgery was the main
procedure performed and the reason for the patient visit. The
data also included information on subject’s age, gender, insur-
ance status (Medicaid, Medicare, private, other), indicators of
the hospital in which the surgery occurred, and NIM.
Identifying Nosocomial Infections
The company utilized a clinical data extraction technique that is
secure, Health Insurance Portability and Accountability Act com-
pliant and electronic to acquire the data from the hospital
sample. Cardinal Health receives encrypted clinical feeds from
the client hospitals’ Laboratory, Admission Discharge and Trans-
fer, and Census systems that are normalized and processed uti-
lizing proprietary technology to produce an NIM. The NIM was
proven to be an effective and accurate identiﬁer of nosocomial
infections in a study by Brossette et al. [82], which also described
the process by which nosocomial infections are identiﬁed. The
NIM was deﬁned as “a patient specimen with a nonduplicate
hospital isolate, where a specimen is a collection of material
obtained from a single source (e.g., blood, urine, sputum, or
wound). A nonduplicate hospital isolate is a nonduplicate isolate
obtained from a specimen collected on or after hospital day 3 or
within 14 days of hospital discharge (within 30 days of discharge
for surgical wound specimens).” [82]
Statistical Analyses
Two types of multivariable regression models were estimated to
isolate the effects of laparoscopic versus open surgery and noso-
comial infections on the payment received by the hospital for
providing care. The ﬁrst revenue model pools all three surgical
procedures and includes binary indicators to adjust costs for the
inﬂuence of each procedure. The second model provides indi-
vidual revenue estimates for each surgical procedure: cholecys-
tectomy, hysterectomy, and appendectomy.
The ﬁrst cost model may be written as:
COST LAP NIM CHOLECYS
HYST
= + + + +
+ +
α α α α
α ε
0 1 2 3
4 qX , (1)
where:
COST = payment received for the surgical procedure;
LAP = binary variable (BV) equal to 1 if the procedure was
laparoscopic and 0 if open;
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NIM = BV equal to 1 if subject incurred a nosocomial infection
and 0 otherwise;
CHOLECYS = BV equal to 1 if surgery was cholecys tectomy
and 0 otherwise;
HYST = BV equal to 1 if surgery was hysterectomy and 0
otherwise;
X = a vector of patient, insurance, and hospital level variables
that affect costs;
a0–a4,q = coefﬁcients to be estimated; and
e = an error term
Reimbursement amounts are right-skewed. To address this
issue, we estimate Generalized Linear Model (GLM) gamma
models. These models have been shown to be more efﬁcient
relative to alternative approaches such as semi-log models [83].
The individual effects of cholecystectomy and hysterectomy on
costs are measured relative to appendectomy, which serves as the
reference group. The vector X includes patient’s age and gender,
insurance status (Medicaid, Medicare, private, or other), and a
series of binary variables that adjust for hospital-speciﬁc effects on
cost of care. The key coefﬁcients of interest area1, whichmeasures
the effect of laparoscopic versus open surgery on costs, and a2,
which quantiﬁes the effects of nosocomial infections on cost of
care. Similar cost equations are estimated separately for each
procedure. These equations include all of the variables in Equation
(1) above, with the exception of indicators of surgery type.
To gain further insight into how laparoscopic versus open
surgeries and nosocomial infections may affect costs, we also
estimate equations predicting hospital length of stay. It is impor-
tant to note that length of stay is not included in the cost models
because it is endogenous and would potentially introduce multi-
collinearity problems as well.
LOS LAP NIM CHOLECYS
HYST
= + + + +
+ +
β β β β
β μ
0 1 2 3
4 yX , (2)
where:
LOS = length of stay in the hospital; and other vari ables are as
described above.
As with cost of care, length of stay models are estimated for
the pooled sample as in Equation (2), and separately for each
surgical modality using GLM gamma models.
Results
The names, descriptions, and summary statistics for the variables
used in this analysis are provided in Table 1. The mean age of
subjects included in our study is 47.4 years. A large number of
hysterectomies are included in our sample, resulting in males
representing only 24% of the sample. More than 20% of the
subjects are insured by Medicare and 7% are insured by Medic-
aid. Nosocomial infections occurred in 3% of patients, and 60%
of surgeries were performed laparoscopically.
The rates for laparoscopic surgery and nosocomial infection
varied by surgery type. For cholecystectomy, the rate of laparo-
scopic surgery was 84%; the corresponding ﬁgures for hysterec-
tomy and appendectomy were 40% and 65%, respectively.
Nosocomial infections rates were 3.6% for cholecystectomies,
2.5% for hysterectomies, and 2.3% for appendectomies.
Table 1 Names and descriptions of study variables (N = 10,731)
Variable name Description Mean
Standard
deviation
Cost Payment received for treatment 8,212.91 7,001.42
Length of Stay Length of stay 3.48 3.34
Lap Binary variable (BV) = 1 if subject received laparoscopic surgery and 0 if open surgery 0.60 0.49
Nosocomial Infection Marker BV = 1 if subject incurred nosocomial infection else = 0 0.03 0.17
Cholecystectomy* BV = 1 if subject received cholecystectomy else = 0 0.32 0.47
Hysterectomy* BV = 1 if subject received hysterectomy else = 0 0.45 0.50
Age Subject’s age in years 47.38 18.22
Male BV = 1 if subject is male else = 0 0.24 0.43
Medicaid† BV = 1 if subject is insured by Medicaid else = 0 0.07 0.26
Medicare† BV = 1 if subject is insured by Medicare else = 0 0.21 0.41
Other Insurance in Tables† BV = 1 if subject is insured by other carrier else = 0 0.10 0.30
Hospital 2‡ BV = 1 if surgery performed at hospital 2 else = 0 0.04 0.19
Hospital 3‡ BV = 1 if surgery performed at hospital 3 else = 0 0.24 0.42
Hospital 4‡ BV = 1 if surgery performed at hospital 4 else = 0 0.02 0.13
Hospital 5‡ BV = 1 if surgery performed at hospital 5 else = 0 0.05 0.21
Hospital 6‡ BV = 1 if surgery performed at hospital 6 else = 0 0.06 0.24
Hospital 7‡ BV = 1 if surgery performed at hospital 7 else = 0 0.03 0.16
Hospital 8‡ BV = 1 if surgery performed at hospital 8 else = 0 0.05 0.22
Hospital 9‡ BV = 1 if surgery performed at hospital 9 else = 0 0.05 0.21
Hospital 10‡ BV = 1 if surgery performed at hospital 10 else = 0 0.03 0.16
Hospital 11‡ BV = 1 if surgery performed at hospital 11 else = 0 0.04 0.19
Hospital 12‡ BV = 1 if surgery performed at hospital 12 else = 0 0.06 0.23
Hospital 13‡ BV = 1 if surgery performed at hospital 13 else = 0 0.04 0.19
Hospital 14‡ BV = 1 if surgery performed at hospital 14 else = 0 0.03 0.16
Hospital 15 BV = 1 if surgery performed at hospital 15 else = 0 0.07 0.25
Hospital 16‡ BV = 1 if surgery performed at hospital 16 else = 0 0.02 0.14
Hospital 17‡ BV = 1 if surgery performed at hospital 17 else = 0 0.01 0.09
Hospital 18‡ BV = 1 if surgery performed at hospital 18 else = 0 0.03 0.17
Hospital 19‡ BV = 1 if surgery performed at hospital 19 else = 0 0.03 0.18
Hospital 20‡ BV = 1 if surgery performed at hospital 20 else = 0 0.02 0.14
Hospital 21‡ BV = 1 if surgery performed at hospital 21 else = 0 0.05 0.21
Hospital 22‡ BV = 1 if surgery performed at hospital 22 else = 0 0.01 0.10
*Appendectomy is the reference group.
†Private insurance is the reference group.
‡Hospital 1 is the reference group.
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Cost of Care Estimates
Table 2 reports the multivariable cost of care estimates for the
overall sample and separate estimates for each surgical proce-
dure. As the table indicates, laparoscopic surgery signiﬁcantly
reduces costs in the overall sample and for all three surgical
procedures individually.
For all three procedures, nosocomial infection has a direct
and highly signiﬁcant impact on increasing the cost of care. Costs
increase with age and are higher for males. In comparison with
private insurance, the reference cohort, subjects insured by Med-
icaid have lower costs. This reﬂects the fact that in most states,
Medicaid pays at a rate of approximately 33% of commercial
insurers. Cost of care tends to be lower for Medicare patients,
possibly reﬂecting lower reimbursement rates under Medicare
relative to privately insured individuals who constitute the refer-
ence cohort. The results also reveal that costs vary substantially
across the hospitals examined in this study. Finally, the full
sample results indicate that the cost of care is highest for
cholecystectomies.
To gain a sense of the degree to which laparoscopic surgery
and nosocomial infections affect reimbursement, we computed
incremental costs using the equation estimates reported in
Table 2. These incremental costs are evaluated at sample means.
The results, provided in Table 3, reveal that the cost savings from
laparoscopic surgery are substantial. The overall sample indi-
cates that laparoscopic surgery reduces costs by $1608. The cost
reduction is even greater for cholecystectomies—$3299. In con-
trast, nosocomial infection has a large positive impact on costs
for all three procedures, increasing costs the most for appendec-
tomies, ($6108) followed by cholecystectomies ($4794) and
hysterectomies ($4528).
Effects on Length of Stay
To better understand the source of these cost differences, multi-
variable estimates of length of stay are reported in Table 4. In
every case, laparoscopic surgery signiﬁcantly reduces length of
stay and nosocomial infection extends it. Length of stay is longer
for older patients and for males. Medicare patients have longer
Table 2 Multivariate cost estimates: overall and by individual procedures (GLM gamma estimates with log link): dependent variable: revenue
Variable
All Cholecystectomy Hysterectomy Appendectomy
N = 10,731
LR test = 3,486
N = 3,473
LR test = 1,041
N = 4,783
LR test = 1,246
N = 2,475
LR test = 1,084
Intercept 8.60† 8.91* 8.34† 8.31†
Lap -0.20† -0.32† -0.20† -0.13†
Nosocomial Infection Marker 0.63† 0.47† 0.66† 0.76†
Cholecystectomy 0.22† — —
Hysterectomy -0.21† — —
Age 0.01† 0.005† 0.01† 0.01†
Male 0.04* 0.07† — -0.004
Medicaid -0.42† -0.43† -0.31† -0.59†
Medicare -0.11† -0.13† -0.11† 0.05
Other Insurance in Tables -0.05† -0.08* 0.05 -0.19†
Hospital 2 0.13† 0.30† 0.06 -0.07
Hospital 3 0.46† 0.49† 0.42† 0.30†
Hospital 4 0.46† 0.63† 0.26† 0.29†
Hospital 5 -0.19† 0.01 -0.19† -0.67†
Hospital 6 0.41† 0.54† 0.35† 0.15
Hospital 7 -0.17† 0.07 -0.29† -0.52†
Hospital 8 0.01 0.08 0.19† -0.38†
Hospital 9 0.23† 0.36† 0.26† -0.18
Hospital 10 -0.31† 0.02 -0.38† -0.57†
Hospital 11 0.45† 0.50† 0.47† 0.19
Hospital 12 0.67† 0.62† 0.70† 0.49†
Hospital 13 0.37† 0.63† 0.21† 0.09
Hospital 14 0.21† 0.43† 0.19† -0.12
Hospital 15 0.10† 0.16† 0.16† -0.24†
Hospital 16 0.11* 0.24† 0.09 -0.10
Hospital 17 0.22 0.28† 0.22* -0.03
Hospital 18 -0.32† -0.01 -0.46† -0.68†
Hospital 19 0.06 0.19† -0.03 -0.04
Hospital 20 0.27† 0.28† 0.34† 0.18
Hospital 21 0.35† 0.40† 0.29† 0.26*
Hospital 22 0.21† 0.28† 0.09 0.10
*Statistically signiﬁcant at the 5% level, two-tailed test.
†Statistically signiﬁcant at the 1% level, two-tailed test.
Hospital 1 is the reference hospital.
GLM, Generalized Linear Model; LR test, likelihood ratio test.
Table 3 Estimated incremental effects of laparoscopic surgery and nosocomial infection on costs ($); overall and by individual procedure
Variable All Cholecystectomy Hysterectomy Appendectomy
Lap -1608* -3299* -1385* -1032*
Nosocomial Infection Marker 5182* 4794* 4528* 6108*
*Statistically signiﬁcant at the 1% level, two-tailed test.
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lengths of stay as well, which is consistent with the notion that
this older patient group has more difﬁcult recovery periods from
these procedures. We ﬁnd substantial variation in length of stay
across hospitals.
As with the cost of care estimates, we computed incremental
effects of laparoscopic surgery and nosocomial infection on
length of stay for the three procedures. These results, presented in
Table 5, indicate that overall, laparoscopic procedures reduce
average length of stay by 1.58 days while nosocomial infections
increase length of stay by 3.16 days.
Discussion
Cholecystectomies, appendectomies, and hysterectomies are
common surgeries with known beneﬁts to patients in need of
these procedures. In many cases, laparoscopic surgery is a safe
and effective alternative to open cholecystectomies, appendecto-
mies, or hysterectomies [1–5]. The present study ﬁnds that the
cost implications of laparoscopic surgery appear favorable as
compared with open surgery for the each of three surgical pro-
cedures examined.
The analysis makes several contributions to understanding
the costs associated with these three surgeries. First and most
signiﬁcantly, we examine more current data comparing the cost
of laparoscopic versus open procedures. Evidence suggests that
as physicians gain experience with laparoscopic procedures, the
cost of care associated with these procedures declines [84]. Using
more current data—when physicians tend to have gained more
experience using laparoscopic procedures—our study shows that
laparoscopic surgery lowers costs signiﬁcantly for all three sur-
gical procedures examined. Second, we use actual amounts paid
by the insurer rather than the charge data typically employed in
previous studies. This provides a better sense of the economic
burden of these procedures on third-party payers. Third, we
examine cholecystectomy, hysterectomy, and appendectomy
using a consistent sample drawn from the same group of hospi-
tals. This helps mitigate sources of heterogeneity stemming from
different time periods and treatment locations. Such heterogene-
ity makes it more difﬁcult to draw comparisons across these
procedures. Fourth, our sample sizes compare favorably with
most previous cost studies of these procedures, and help to
ensure that we have sufﬁcient statistical power to detect mean-
Table 4 Multivariate length of stay estimates: overall and by individual procedures (GLM gamma estimates with log link): dependent variable: length of
stay
Variable
All Cholecystectomy Hysterectomy Appendectomy
N = 10,731;
LR test = 3,676
N = 3,473;
LR test = 1,496
N = 4,783;
LR test = 1,002
N = 2,475;
LR test = 1,048
Intercept 0.94† 1.03† 0.82† 1.23†
Lap -0.45† -0.38† -0.53† -0.39†
Nosocomial Infection Marker 0.91† 0.88† 0.91† 0.98†
Cholecystectomy 0.38† — — —
Hysterectomy -0.25† — — —
Age 0.01† 0.01† 0.01† 0.01†
Male 0.04† 0.07 0.01
Medicaid 0.17† 0.13† 0.23† 0.15†
Medicare 0.18† 0.13† 0.18† 0.40†
Other Insurance in Tables 0.08† 0.05 0.02 0.14†
Hospital 2 -0.08* 0.21 -0.18† -0.47†
Hospital 3 0.15† 0.44† -0.03 -0.17*
Hospital 4 0.01 0.29† -0.22† -0.25*
Hospital 5 0.03 0.26† -0.04 -0.50†
Hospital 6 0.07* 0.42† -0.09* -0.43†
Hospital 7 -0.18† 0.19* -0.38† -0.56†
Hospital 8 0.14† 0.23† 0.25† -0.18
Hospital 9 -0.21† 0.05 -0.23† -0.63†
Hospital 10 0.01 0.24* -0.08* -0.26*
Hospital 11 0.18† 0.40† -0.05 -0.10
Hospital 12 0.04 0.10 0.09* -0.40†
Hospital 13 0.01 0.37† -0.18† -0.34†
Hospital 14 -0.10* 0.27† -0.29† -0.41†
Hospital 15 -0.10† -0.05* -0.13† -0.27†
Hospital 16 -0.18† 0.09 -0.19† -0.63†
Hospital 17 0.15* 0.01 -0.10 -0.56†
Hospital 18 0.14† 0.37† 0.06 -0.19
Hospital 19 0.15† 0.31† 0.05 -0.10
Hospital 20 -0.05 0.18† -0.0001 -0.48†
Hospital 21 -0.16† 0.19* -0.34† -0.26*
Hospital 22 0.04 0.16 -0.25† 0.01
*Statistically signiﬁcant at the 5% level, two-tailed test.
†Statistically signiﬁcant at the 1% level, two-tailed test.
Hospital 1 is the reference hospital.
GLM, Generalized Linear Model; LR test, likelihood ratio test.
Table 5 Estimated incremental effects of laparoscopic surgery and nosocomial infection on LOS: overall and by individual procedure
Variable All Cholecystectomy Hysterectomy Appendectomy
Lap -1.58* -1.84* -1.46* -1.16*
Nosocomial Infection Marker 3.16* 4.29* 2.52* 2.90*
*Statistically signiﬁcant at the 1% level, two-tailed test.
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ingful differences where they exist. Finally, our study utilizes a
unique database that tracks nosocomial infections, allowing us to
quantify the large economic burden when such infections occur
following these procedures, whether open or laparoscopic.
Further Cost Advantages of Laparoscopic Surgery
There is evidence to suggest that our estimated effects of laparo-
scopic surgery on the cost of care are conservative. Our models
adjust for nosocomial infection, but studies have found that
laparoscopic surgery is protective against these infections, reduc-
ing the rate of these infections by 50% or more [85]. If so, an
additional cost saving from laparoscopic surgery would result
from reductions in the incidence of nosocomial infections, poten-
tially reducing those costs by at least 50% or more.
Limitations
There are some limitations to our data and analyses that must be
recognized. First, although we have a large number of patients,
our sample comes from 22 hospitals. While these hospitals vary
considerably in size and geographic location, they may not be
representative of hospitals nationally so the ﬁndings may not be
generalizable to particular hospitals or settings. Second, while we
controlled for a number of potential confounders, there may be
other important factors for which we were unable to adjust. For
example, we were unable to identify if surgeries were performed
on an emergent or elective basis. As the vast majority of appen-
dectomies are emergent while most hysterectomies are elective,
failure to include this potential confounder likely introduced
little bias into these estimates. In contrast, cholecystectomies are
generally performed both emergently and electively and it would
have been desirable to control for this.
Conclusion
Our analysis ﬁnds that laparoscopic surgery reduces the cost of
care substantially for cholecystectomy, hysterectomy, and appen-
dectomy. Laparoscopic surgery also reduces length of stay sig-
niﬁcantly for each procedure. Although the merit of laparoscopic
surgery for appendectomy is currently less conclusive than for the
other two procedures, we ﬁnd that it leads to signiﬁcantly lower
costs and reduced length of stay for this procedure as well. As
others have argued, laparoscopic appendectomy surgery may be
an attractive alternative to the open procedure given that it
confers beneﬁts valued by patients, such as reduced hospitals
stays and fewer complication rates [86].
As providers gain experience with laparoscopic procedures, it
would be useful to update cost of care estimates to determine if
this greater experience leads to efﬁciency gains in terms of lower
costs. Another important direction for future research is to
perform comparative cost of care analyses for other procedures
such as colectomy for which laparoscopic approaches are becom-
ing more popular.
Source of ﬁnancial support: This study was supported by Ethicon-Endo
Surgery, Cincinnati, OH, USA.
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